AAAAAA

   
Results: 1-9 |
Results: 9
Mechanisms involved in stimulation of human immunodeficiency virus type 1 replication by aminooxypentane RANTES
Authors: Marozsan, AJ Torre, VS Johnson, M Ball, SC Cross, JV Templeton, DJ Quinones-Mateu, ME Offord, RE Arts, EJ
Citation: Aj. Marozsan et al., Mechanisms involved in stimulation of human immunodeficiency virus type 1 replication by aminooxypentane RANTES, J VIROLOGY, 75(18), 2001, pp. 8624-8638
Combination of CCR5 and CXCR4 inhibitors in therapy of human immunodeficiency virus type 1 infection: In vitro studies of mixed virus infections
Authors: Rusconi, S Catamancio, SL Citterio, P Bulgheroni, E Croce, F Herrmann, SH Offord, RE Galli, M Hirsch, MS
Citation: S. Rusconi et al., Combination of CCR5 and CXCR4 inhibitors in therapy of human immunodeficiency virus type 1 infection: In vitro studies of mixed virus infections, J VIROLOGY, 74(19), 2000, pp. 9328-9332
Variable sensitivity of CCR5-tropic human immunodeficiency virus type 1 isolates to inhibition by RANTES analogs
Authors: Torre, VS Marozsan, AJ Albright, JL Collins, KR Hartley, O Offord, RE Quinones-Mateu, ME Arts, EJ
Citation: Vs. Torre et al., Variable sensitivity of CCR5-tropic human immunodeficiency virus type 1 isolates to inhibition by RANTES analogs, J VIROLOGY, 74(10), 2000, pp. 4868-4876
Candidate microbicides block HIV-1 infection of human immature Langerhans cells within epithelial tissue explants
Authors: Kawamura, T Cohen, SS Borris, DL Aquilino, EA Glushakova, S Margolis, LB Orenstein, JM Offord, RE Neurath, AR Blauvelt, A
Citation: T. Kawamura et al., Candidate microbicides block HIV-1 infection of human immature Langerhans cells within epithelial tissue explants, J EXP MED, 192(10), 2000, pp. 1491-1500
Positive and negative labeling of human proinsulin, insulin, and C-peptidewith stable isotopes - New tools for in vivo pharmacokinetic and metabolicstudies
Authors: Stocklin, R Arrighi, JF Hoang-Van, K Vu, L Cerini, F Gilles, N Genet, R Markussen, J Offord, RE Rose, K
Citation: R. Stocklin et al., Positive and negative labeling of human proinsulin, insulin, and C-peptidewith stable isotopes - New tools for in vivo pharmacokinetic and metabolicstudies, METH MOL B, 146, 2000, pp. 293-315
Aminooxypentane-RANTES, an inhibitor of R5 human immunodeficiency virus type 1, increases the interferon gamma to interleukin 10 ratio without impairing cellular proliferation
Authors: Rusconi, S La Seta-Catamancio, S Kurtagic, S Galazzi, M Arienti, D Trabattoni, D Wilken, J Thompson, DA Offord, RE Galli, M Clerici, M
Citation: S. Rusconi et al., Aminooxypentane-RANTES, an inhibitor of R5 human immunodeficiency virus type 1, increases the interferon gamma to interleukin 10 ratio without impairing cellular proliferation, AIDS RES H, 15(10), 1999, pp. 861-867
Effective inhibition of HIV-1 isolated from patients with acute primary HIV-1 infection by aminooxypentane-RANTES
Authors: Rusconi, S Merrill, DP La Seta-Catamancio, S Citterio, P Offord, RE Hirsch, MS
Citation: S. Rusconi et al., Effective inhibition of HIV-1 isolated from patients with acute primary HIV-1 infection by aminooxypentane-RANTES, AIDS, 13(9), 1999, pp. 1144-1145
Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variants
Authors: Mosier, DE Picchio, GR Gulizia, RJ Sabbe, R Poignard, P Picard, L Offord, RE Thompson, DA Wilken, J
Citation: De. Mosier et al., Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variants, J VIROLOGY, 73(5), 1999, pp. 3544-3550
Amino-terminally modified RANTES analogues demonstrate differential effects on RANTES receptors
Authors: Proudfoot, AEI Buser, R Borlat, F Alouani, S Soler, D Offord, RE Schroder, JM Power, CA Wells, TNC
Citation: Aei. Proudfoot et al., Amino-terminally modified RANTES analogues demonstrate differential effects on RANTES receptors, J BIOL CHEM, 274(45), 1999, pp. 32478-32485
Risultati: 1-9 |